By |

Profile

MyoKardia Inc is a US-based clinical-stage biopharmaceutical company which is engaged in discovering, developing and commercializing targeted therapies for the treatment of serious and neglected rare cardiovascular diseases. The company mainly focuses on the treatment of heritable cardiomyopathies and genetically-driven forms of heart failure that result from biomechanical defects in cardiac muscle contraction. It uses its medicine platform to generate an initial pipeline of therapeutic programs for the chronic treatment of the two most common forms of heritable cardiomyopathy-hypertrophic cardiomyopathy (HCM) and dilated cardiomyopathy.

Contact Information

Website: www.myokardia.com
Email: info@myokardia.com
Main Phone: +1 650 741-0900
Address: 333 Allerton Avenue
City / Town: South San Francisco
Country: USA
Postal Code: 94080

Issuer Information

Exchange: NGS
CEO: Anastasios Gianakakos
Employees: 156
NAICS: Pharmaceutical Preparation Manufacturing(325412)


Gathering Data... Please wait

Profile

MyoKardia Inc is a US-based clinical-stage biopharmaceutical company which is engaged in discovering, developing and commercializing targeted therapies for the treatment of serious and neglected rare cardiovascular diseases. The company mainly focuses on the treatment of heritable cardiomyopathies and genetically-driven forms of heart failure that result from biomechanical defects in cardiac muscle contraction. It uses its medicine platform to generate an initial pipeline of therapeutic programs for the chronic treatment of the two most common forms of heritable cardiomyopathy-hypertrophic cardiomyopathy (HCM) and dilated cardiomyopathy.

Contact Information

Website: www.myokardia.com
Email: info@myokardia.com
Main Phone: +1 650 741-0900
Address: 333 Allerton Avenue
City / Town: South San Francisco
Country: USA
Postal Code: 94080

Issuer Information

Exchange: NGS
CEO: Anastasios Gianakakos
Employees: 156
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 45.52 $ 0.84 (1.88%)
Last Price 45.52 Change $ 0.84 Change % 1.88 Tick N/A
Bid 39.39 Bid Size 200.00 Ask 49.41 Ask Size 200.00
Open 44.86 High 45.97 Low 44.50 Prev Close 44.68
Last Trade Volume 295,082 52 Wk Hi 67.79 52 Wk Low 39.16
Market Cap 1.8 bi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 40,270,711.00 EPS (TTM) -1.31 PE Ratio N/A Exchange NGS
  Last 3 Mo Last 12 Mo
Number of Insider Trades 17 82
Number of Buys 7 24
Number of Sells 10 58
Net Activity -612 -15386926
Last 10 Buys Shares
Wendy L. Yarno 1,000
Anastasios Gianakakos 1,000
Anastasios Gianakakos 1,000
Mark L. Perry 1,000
Jonathan C. Fox 1,000
Last 10 Sell Shares
Anastasios Gianakakos 1,000
Anastasios Gianakakos 1,000
Anastasios Gianakakos 1,000
Anastasios Gianakakos 1,000
Anastasios Gianakakos 1,000
Jake Bauer 1,000
Jake Bauer 1,000
Anastasios Gianakakos 1,000
Anastasios Gianakakos 1,000
Jake Bauer 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 83 83 83 83
Low Target Price Estimate 64 64 64 64
Mean Target Price Estimate 74 74 74 74
Standard Deviation 7.65 7.65 7.65 7.65
Date of Most Recent Estimate 05/21/18 05/21/18 05/21/18 05/21/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 5 5 5 5
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1 1 1 1